- Home
- ANEB vs NTIP Comparison
ANEB vs NTIP Comparison
Compare ANEB & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- NTIP
- Stock Information
- Founded
- ANEB 2020
- NTIP 1990
- Country
- ANEB United States
- NTIP United States
- Employees
- ANEB N/A
- NTIP N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- ANEB Health Care
- NTIP Miscellaneous
- Exchange
- ANEB Nasdaq
- NTIP Nasdaq
- Market Cap
- ANEB 111.8M
- NTIP 32.0M
- IPO Year
- ANEB 2021
- NTIP 1998
- Fundamental
- Price
- ANEB $2.64
- NTIP $1.56
- Analyst Decision
- ANEB Buy
- NTIP
- Analyst Count
- ANEB 2
- NTIP 0
- Target Price
- ANEB $8.00
- NTIP N/A
- AVG Volume (30 Days)
- ANEB 20.2K
- NTIP 8.8K
- Earning Date
- ANEB 11-14-2025
- NTIP 10-24-2025
- Dividend Yield
- ANEB N/A
- NTIP 6.67%
- EPS Growth
- ANEB N/A
- NTIP N/A
- EPS
- ANEB N/A
- NTIP N/A
- Revenue
- ANEB N/A
- NTIP $150,000.00
- Revenue This Year
- ANEB N/A
- NTIP N/A
- Revenue Next Year
- ANEB N/A
- NTIP N/A
- P/E Ratio
- ANEB N/A
- NTIP N/A
- Revenue Growth
- ANEB N/A
- NTIP N/A
- 52 Week Low
- ANEB $0.80
- NTIP $1.16
- 52 Week High
- ANEB $3.42
- NTIP $1.90
- Technical
- Relative Strength Index (RSI)
- ANEB 55.13
- NTIP 47.22
- Support Level
- ANEB $2.50
- NTIP $1.48
- Resistance Level
- ANEB $2.76
- NTIP $1.54
- Average True Range (ATR)
- ANEB 0.13
- NTIP 0.05
- MACD
- ANEB 0.00
- NTIP -0.00
- Stochastic Oscillator
- ANEB 61.82
- NTIP 20.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.